Thesis defense Thomas van Ravesteyn: genetic modification with short DNA molecules


Since heredity can play an important role in cancer it is of great importance that we try to understand how different genetic variations influence our health. During his PhD research Thomas van Ravesteyn studied how very short DNA molecules (ssODNs) can be used to genetically modify cells accurately in the lab. This technology allows scientists to distinguish between harmless and harmful genetic variants that can cause colorectal cancer, for example. In collaboration with other hospitals these methods are currently finding their way to clinical practice. On Friday September 27th he will defend his thesis at Vrije Universiteit Amsterdam.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.